|
1
|
Cascella M, Rajnik M, Aleem A, Dulebohn SC
and Di Napoli R: Features, evaluation, and treatment of coronavirus
(COVID-19). In: StatPearls Publishing, Treasure Island (FL),
2020.
|
|
2
|
Al-Quteimat OM and Amer AM: The impact of
the COVID-19 pandemic on cancer patients. Am J Clin Oncol.
43:452–455. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gupta K, Gandhi S, Mebane A III, Singh A,
Vishnuvardhan N and Patel E: Cancer patients and COVID-19:
Mortality, serious complications, biomarkers, and ways forward.
Cancer Treat Res Commun. 26(100285)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuderer NM, Choueiri TK, Shah DP, Shyr Y,
Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G
Jr, et al: Clinical impact of COVID-19 on patients with cancer
(CCC19): A cohort study. Lancet. 395:1907–1918. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Johannesen TB, Smeland S, Aaserud S,
Buanes EA, Skog A, Ursin G and Helland Å: COVID-19 in cancer
patients, risk factors for disease and adverse outcome, a
population-based study from norway. Front Oncol.
11(652535)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee KA, Ma W, Sikavi DR, Drew DA, Nguyen
LH, Bowyer RCE, Cardoso MJ, Fall T, Freidin MB, Gomez M, et al:
Cancer and risk of COVID-19 through a general community survey.
Oncologist. 26:e182–e185. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Košir U, Loades M, Wild J, Wiedemann M,
Krajnc A, Roškar S and Bowes L: The impact of COVID-19 on the
cancer care of adolescents and young adults and their well-being:
Results from an online survey conducted in the early stages of the
pandemic. Cancer. 126:4414–4422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thomas SJ, Perez JL, Lockhart SP,
Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, Türeci Ö,
Şahin U, et al: Efficacy and safety of the BNT162b2 mRNA COVID-19
vaccine in participants with a history of cancer: Subgroup analysis
of a global phase 3 randomized clinical trial. Vaccine.
40:1483–1492. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Solaini L, Bencivenga M, Rosa F, D'ignazio
A, Marino E, Ministrini S, Sofia S, Sacco M, Mura G, Rausa E, et
al: Consequences of the COVID-19 pandemic on the diagnosis and
treatment of gastric cancer in referral centers in Italy. Tumori.
109:121–128. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mathews AS, Paul A, Yu IS, McGahan C,
Bhang E, Villa D, Gelmon K, Avina-Zubieta A, Gerrie AS, Lee U, et
al: The clinical impact of COVID-19 on patients with cancer in
British Columbia: An observational study. Heliyon.
12(e12140)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dinmohamed AG, Visser O, Verhoeven RHA,
Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens VEPP,
Nagtegaal ID and Siesling S: Fewer cancer diagnoses during the
COVID-19 epidemic in the Netherlands. Lancet Oncol. 21:750–751.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mendonça E Silva DR, Fernandes GA, França
E Silva ILA and Curado MP: Cancer stage and time from cancer
diagnosis to first treatment during the COVID-19 pandemic. Semin
Oncol. 50:60–65. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Baba K, Kawamoto M, Mamishin K, Uematsu M,
Kiyohara H, Hirota A, Takahashi N, Fukuda M, Kusuhara S, Nakajima
H, et al: The impact of the COVID-19 pandemic on perioperative
chemotherapy for breast cancer. Cancer Med. 12:12095–12105.
2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sha Z, Chang K, Mi J, Liang Z, Hu L, Long
F, Shi H, Lin Z, Wang X and Pei X: The impact of the COVID-19
pandemic on lung cancer patients. Ann Palliat Med. 9:3373–3378.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aboueshia M, Hussein MH, Attia AS,
Swinford A, Miller P, Omar M, Toraih EA, Saba N, Safah H, Duchesne
J and Kandil E: Cancer and COVID-19: Analysis of patient outcomes.
Future Oncol. 17:3499–3510. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rucinska M and Nawrocki S: COVID-19
pandemic: Impact on cancer patients. Int J Environ Res Public
Health. 19(12470)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Resende CAA, Fernandes Cruz HM, Costa E
Silva M, Paes RD, Dienstmann R, Barrios CHE, Goncalves AC, Cascelli
FGA, Souto AKBA, Oliveira LC, et al: Impact of the COVID-19
pandemic on cancer staging: An analysis of patients with breast
cancer from a community practice in Brazil. JCO Glob Oncol.
8(e2200289)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
de Sousa CFPM, de Castro Junior G,
Starling MTM, Restini FCF, Rodrigues AN, de Castro Ribeiro HS,
Arruda GV, Hanna SA, de Moraes FY and Marta GN: Impact of the
COVID-19 outbreak on cancer staging in Brazil. Clin Oncol (R Coll
Radiol). 35:e404–e406. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Arndt V, Doege D, Fröhling S, Albers P,
Algül H, Bargou R, Bokemeyer C, Bornhäuser M, Brandts CH, Brossart
P, et al: Cancer care in German centers of excellence during the
first 2 years of the COVID-19 pandemic. J Cancer Res Clin Oncol.
149:913–919. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vanni G, Pellicciaro M, Materazzo M, Bruno
V, Oldani C, Pistolese CA, Buonomo C, Caspi J, Gualtieri P,
Chiaravalloti A, et al: Lockdown of breast cancer screening for
COVID-19: Possible scenario. In Vivo. 34:3047–3053. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Garassino MC, Whisenant JG, Huang LC,
Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini
AC, et al: COVID-19 in patients with thoracic malignancies
(TERAVOLT): First results of an international, registry-based,
cohort study. Lancet Oncol. 21:914–922. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tokunaga M, Yoshikawa T, Boku N, Nishida
Y, Tanahashi T, Yamada T, Haruta S, Etoh T, Hirahara N, Kawachi Y,
et al: Impact of COVID-19 on gastric cancer treatment in Japanese
high-volume centers: A JCOG stomach cancer study group survey. Surg
Today. 52:231–238. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Priou S, Lamé G, Zalcman G, Wislez M, Bey
R, Chatellier G, Cadranel J, Tannier X, Zelek L, Daniel C, et al:
Influence of the SARS-CoV-2 outbreak on management and prognosis of
new lung cancer cases, a retrospective multicentre real-life cohort
study. Eur J Cancer. 173:33–40. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fujita S, Sakuramoto S, Miyawaki Y,
Morimoto Y, Ebara G, Nishibeppu K, Oya S, Fujihata S, Lee S, Sugita
H, et al: Impact of the first era of the coronavirus disease 2019
pandemic on gastric cancer patients: A single-institutional
analysis in Japan. Int J Clin Oncol. 27:930–939. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Suh MA, Park SB, Kwak MS, Yoon JY and Cha
JM: Impact of the COVID-19 pandemic on esophagogastroduodenoscopy
and gastric cancer claims in South Korea: A nationwide,
population-based study. Yonsei Med J. 64:549–557. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lara OD, Smith M, Wang Y, O'Cearbhaill RE,
Blank SV, Kolev V, Carr C, Knisely A, McEachron J, Gabor L, et al:
COVID-19 outcomes of patients with gynecologic cancer in New York
City: An updated analysis from the initial surge of the pandemic.
Gynecol Oncol. 164:304–310. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Arrieta O, Lara-Mejía L, Bautista-GonzÁlez
E, Heredia D, Turcott JG, BarrÓn F, Ramos-Ramírez M,
Cabrera-Miranda L, Salinas Padilla MÁ, Aguerrebere M, et al:
Clinical impact of the COVID-19 pandemic in Mexican patients with
thoracic malignancies. Oncologist. 26:1035–1043. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Provencio M, Mazarico Gallego JM, Calles
A, Antoñanzas M, Pangua C, Mielgo Rubio X, Nadal E, Castro RL,
López-Martín A, Del Barco E, et al: Lung cancer patients with
COVID-19 in Spain: GRAVID study. Lung Cancer. 157:109–115.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mato AR, Roeker LE, Lamanna N, Allan JN,
Leslie L, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, et
al: Outcomes of COVID-19 in patients with CLL: A multicenter
international experience. Blood. 136:1134–1143. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ospina AV, Bruges R, Mantilla W, Triana I,
Ramos P, Aruachan S, Quiroga A, Munevar I, Ortiz J, Llinás N, et
al: Impact of COVID-19 infection on patients with cancer:
Experience in a Latin American Country: The ACHOCC-19 study.
Oncologist. 26:e1761–e1773. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lièvre A, Turpin A, Ray-Coquard I, Le
Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O,
Aldabbagh K, et al: Risk factors for coronavirus disease 2019
(COVID-19) severity and mortality among solid cancer patients and
impact of the disease on anticancer treatm: A French nationwide
cohort study (GCO-002 CACOVID-19). Eur J Cancer. 141:62–81.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fox L, Monroy-Iglesias MJ, Aggarwal A,
Haire K, Purushotham A, Spicer J, Papa S, Rigg A, Dolly S, Sullivan
R and Van Hemelrijck M: Association between COVID-19 burden and
delays to diagnosis and treatment of cancer patients in England. J
Cancer Policy. 31(100316)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Necula L, Matei L, Dragu D, Neagu AI,
Mambet C, Nedeianu S, Bleotu C, Diaconu CC and Chivu-Economescu M:
Recent advances in gastric cancer early diagnosis. World J
Gastroenterol. 25:2029–2044. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tan YK and Fielding JW: Early diagnosis of
early gastric cancer. Eur J Gastroenterol Hepatol. 18:821–829.
2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu SY, Tung HJ, Huang KH, Lee CB, Tsai TH
and Chang YC: The protective effects of influenza vaccination in
elderly patients with breast cancer in Taiwan: A real-world
evidence-based study. Vaccines (Basel). 10(1144)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Coleman CN, Mansoura MK, Marinissen MJ,
Grover S, Dosanjh M, Brereton HD, Roth L, Wendling E, Pistenmaa DA
and O'Brien DM: Achieving flexible competence: Bridging the
investment dichotomy between infectious diseases and cancer. BMJ
Glob Health. 5(e003252)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lashley FR: Emerging infectious diseases:
Vulnerabilities, contributing factors and approaches. Expert Rev
Anti Infect Ther. 2:299–316. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tsamakis K, Gavriatopoulou M, Schizas D,
Stravodimou A, Mougkou A, Tsiptsios D, Sioulas V, Spartalis E,
Sioulas AD, Tsamakis C, et al: Oncology during the COVID-19
pandemic: Challenges, dilemmas and the psychosocial impact on
cancer patients. Oncol Lett. 20:441–447. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Glidden C, Howden K, Romanescu RG, Hatala
A, Scott I, Deleemans JM, Chalifour K, Eaton G, Gupta AA, Bolton
JM, et al: Psychological distress and experiences of adolescents
and young adults with cancer during the COVID-19 pandemic: A
cross-sectional survey. Psychooncology. 31:631–640. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Edge R, Meyers J, Tiernan G, Li Z,
Schiavuzzi A, Chan P, Vassallo A, Morrow A, Mazariego C, Wakefield
CE, et al: Cancer care disruption and reorganisation during the
COVID-19 pandemic in Australia: A patient, carer and healthcare
worker perspective. PLoS One. 16(e0257420)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cancino RS, Su Z, Mesa R, Tomlinson GE and
Wang J: The impact of COVID-19 on cancer screening: Challenges and
opportunities. JMIR Cancer. 6(e21697)2020.PubMed/NCBI View
Article : Google Scholar
|
|
43
|
Parmar HS, Nayak A, Gavel PK, Jha HC,
Bhagwat S and Sharma R: Cross talk between COVID-19 and breast
cancer. Curr Cancer Drug Targets. 21:575–600. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Brown JM, Wasson MD and Marcato P:
Triple-negative breast cancer and the COVID-19 pandemic: Clinical
management perspectives and potential consequences of infection.
Cancers (Basel). 13(296)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Blevins TR, Lo SB, Coker CA, Arrato NA,
Reisinger SA, Shields PG and Andersen BL: COVID-19 or cancer
stress? Anxiety and depressive symptoms in patients with advanced
lung cancer. Int J Behav Med. 31:325–330. 2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Beltramo G, Cottenet J, Mariet AS, Georges
M, Piroth L, Tubert-Bitter P, Bonniaud P and Quantin C: Chronic
respiratory diseases are predictors of severe outcome in COVID-19
hospitalised patients: A nationwide study. Eur Respir J.
58(2004474)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
He ZF, Zhong NS and Guan WJ: Impact of
chronic respiratory diseases on the outcomes of COVID-19. Arch
Bronconeumol. 58:5–7. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sahu KK and Cerny J: Managing patients
with hematological malignancies during COVID-19 pandemic. Expert
Rev Hematol. 13:787–793. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sud A, Jones ME, Broggio J, Loveday C,
Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA, Gronthoud F, et
al: Collateral damage: The impact on outcomes from cancer surgery
of the COVID-19 pandemic. Ann Oncol. 31:1065–1074. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Aktas G: Hematological predictors of novel
coronavirus infection. Rev Assoc Med Bras (1992). 67 (Suppl
1):S1–S2. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Khalid A, Ali Jaffar M, Khan T, Abbas Lail
R, Ali S, Aktas G, Waris A, Javaid A, Ijaz N and Muhammad N:
Hematological and biochemical parameters as diagnostic and
prognostic markers in SARS-COV-2 infected patients of Pakistan: A
retrospective comparative analysis. Hematology. 26:529–542.
2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Atak BM, Kahveci G, Bilgin S, Kurtkulagi
O, Duman TT, Demirkol ME and Aktas G: Haemoglobin and red cell
distribution width levels in internal medicine patients indicate
recurrent hospital admission during COVID-19. Fam Med Prim Care
Rev. 24:32–36. 2022.
|
|
53
|
Atak BM, Bilgin S, Kurtkulagi O, Kahveci
G, Duman TT, Sagdic T and Aktas G: Frailty in diabetic subjects
during COVID-19 and its association with HbA1c, mean platelet
volume and monocyte/lymphocyte ratio. Clin Diabetol. 11:119–126.
2022.
|
|
54
|
Catal O, Ozer B, Sit M, Aktas G and Erkol
H: The role of monocyte to lymphocyt ratio in predicting metastasis
in rectal cancer. Ann Med Res. 28(527)2021.
|
|
55
|
Sit M, Aktas G, Ozer B, Kocak MZ, Erkus E,
Erkol H, Yaman S and Savli H: Mean platelet volume: An overlooked
herald of malignant thyroid nodules. Acta Clin Croat. 58:417–420.
2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Karagoz I, Aktas G, Yoldas H, Yildiz I,
Ogun MN, Bilgi M and Demirhan A: Association between hemogram
parameters and survival of critically Ill patients. J Intensive
Care Med. 34:511–513. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Passaro A, Bestvina C, Velez Velez M,
Garassino MC, Garon E and Peters S: Severity of COVID-19 in
patients with lung cancer: Evidence and challenges. J Immunother
Cancer. 9(e002266)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Matenge S, Sturgiss E, Desborough J, Hall
Dykgraaf S, Dut G and Kidd M: Ensuring the continuation of routine
primary care during the COVID-19 pandemic: A review of the
international literature. Fam Pract. 39:747–761. 2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Lin JA, Braun HJ, Schwab ME, Pierce L,
Sosa JA and Wick EC: Pandemic recovery: Persistent disparities in
access to elective surgical procedures. Ann Surg. 277:57–65.
2023.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Mitura K: The impact of COVID-19 pandemic
on critical care and surgical services availability. Crit Care
Innov. 3:43–50. 2020.
|
|
61
|
Mullangi S, Aviki EM, Chen Y, Robson M and
Hershman DL: Factors associated with cancer treatment delay among
patients diagnosed with COVID-19. JAMA Netw Open.
5(e2224296)2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Addabbo F, Giotta M, Mincuzzi A, Minerba
AS, Prato R, Fortunato F, Bartolomeo N and Trerotoli P: No excess
of mortality from lung cancer during the COVID-19 pandemic in an
area at environmental risk: Results of an explorative analysis. Int
J Environ Res Public Health. 20(5522)2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z,
Zhang Z, You H, Wu M, Zheng Q, et al: Patients with cancer appear
more vulnerable to SARS-CoV-2: A multicenter study during the
COVID-19 outbreak. Cancer Discov. 10:783–791. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Poortmans PM, Guarneri V and Cardoso MJ:
Cancer and COVID-19: What do we really know? Lancet. 395:1884–1885.
2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Yang F, Shi S, Zhu J, Shi J, Dai K and
Chen X: Clinical characteristics and outcomes of cancer patients
with COVID-19. J Med Virol. 92:2067–2073. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Desai A, Gupta R, Advani S, Ouellette L,
Kuderer NM, Lyman GH and Li A: Mortality in hospitalized patients
with cancer and coronavirus disease 2019: A systematic review and
meta-analysis of cohort studies. Cancer. 127:1459–1468.
2021.PubMed/NCBI View Article : Google Scholar
|
